Peter M Bruno

7PUBLICATIONS
21CO-AUTHORS
Molecular targetsImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 02, 2025
Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity.

Tianyi Liu, Meng Zhang, Tatyanah Farsh

|Dec 22, 2023
The genomics revolution comes to the immunopeptidome.

Peter M Bruno

|Jan 02, 2023
High-throughput, targeted MHC class I immunopeptidomics using a functional genetics screening platform.

Peter M Bruno, Richard T Timms, Nouran S Abdelfattah

|Apr 19, 2020
Author Correction: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer.

Ruogu Qi, Yongheng Wang, Peter M Bruno

|Feb 09, 2018
Publisher Correction: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer.

Ruogu Qi, Yongheng Wang, Peter M Bruno

|Dec 20, 2017
Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer.

Ruogu Qi, Yongheng Wang, Peter M Bruno

Pageof 2

Frequent Collaborators

3 joint publications

Qixian Chen

3 joint publications

Alexandre Detappe

1 joint publications

Richard T Timms

1 joint publications

Duane R Wesemann